Serotonin Uptake Inhibitors - Adverse effects
Research News and Information

Sunday, November 22, 2009

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders.

13 Oct 2009 OBJECTIVE: There are case reports about antidepressants causing arthritis and arthralgia, and the majority of these reports deal with atypical antidepressants, which are serotonin receptor 2A (5-HT(2A))-blocking substances. The aim of this study was ... Read more...

[Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices]

3 Oct 2009 INTRODUCTION: The consumption of benzodiazepines (BZ) and cyclopyrrolones (CP) has attracted great interest in recent years due to the serious side-effects associated with these drugs. Two medical practices introduced a more restrictive approach to ... Read more...

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

29 Sep 2009 OBJECTIVE: To investigate the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy outcomes. DESIGN: Prospective cohort study. SETTING: Department of Obstetrics, Aarhus University Hospital, Aarhus, Denmark. ... Read more...

Latest indexed articles for 'Serotonin Uptake Inhibitors - Adverse effects'

These are the very latest articles for this heading:

• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. 30 Oct 2009
• SSRIs and congenital defects. Spontaneous publishing and academic miscarriages (SPAM). 19 Oct 2009
• Women should give informed consent before starting SSRIs. 19 Oct 2009
• SSRIs and heart defects in neonates. 19 Oct 2009
• SSRIs and congenital defects. Case registers in pregnancy? 19 Oct 2009
• Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders. 13 Oct 2009
• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Drug fails to subdue repetitive behavior in children with autism spectrum disorders. 29 Sep 2009
• Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy. 29 Sep 2009
• Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. 29 Sep 2009
• Antidepressant use and preterm birth. 29 Sep 2009
• Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data. 29 Sep 2009
• Benefits exceed risks of newer antidepressant medications in youth--maybe not. 29 Sep 2009
• Benefits exceed risks of newer antidepressant medications in youth--maybe. 29 Sep 2009
• Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. 26 Sep 2009
• Probable fluoxetine-induced carotidynia. 24 Sep 2009
• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. 21 Sep 2009
• Selective serotonin reuptake inhibitors and congenital malformations. 21 Sep 2009
• Linezolid: a review of safety and tolerability. 30 Aug 2009
• Sexual side-effects of contemporary antidepressants: review. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Serotonin Uptake Inhibitors'

Definition: Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here.

Registry Number: 0

Descriptor UI: D017367

Alternative terms: Serotonin Uptake Inhibitors; Uptake Inhibitors, 5-HT; Uptake Inhibitors, 5 HT; 5-HT Uptake Inhibitors; 5 HT Uptake Inhibitors; Inhibitors, 5-Hydroxytryptamine Uptake; Inhibitors, 5 Hydroxytryptamine Uptake; Uptake Inhibitors, 5-Hydroxytryptamine; Uptake Inhibitors, 5 Hydroxytryptamine; Inhibitors, Serotonin Reuptake; Reuptake Inhibitors, Serotonin; Serotonin Reuptake Inhibitors; Inhibitors, Serotonin Uptake; Uptake Inhibitors, Serotonin; Inhibitors, 5-HT Uptake; Inhibitors, 5 HT Uptake; 5-Hydroxytryptamine Uptake Inhibitors; 5 Hydroxytryptamine Uptake Inhibitors;

Related Mesh Headings: Antidepressive Agents, Second-Generation; Adrenergic Uptake Inhibitors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.519.625.600.850; D27.505.519.625.850.900; D27.505.696.577.600.850; D27.505.696.577.850.900;

History Note: 93

Technical Notes: GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN UPTAKE INHIB